In this review, we summarized recent advances focusing on the role of NLRP3 inflammasome in atherosclerosis, cardiomyopathy, and other common CVDs, and we discussed the therapeutic potential of inhibiting NLRP3 inflammasome. Here, NLRP3 is linked to cardiomyopathy.